Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)
Bonora, S., Rusconi, S., Calcagno, A., Bracchi, M., Viganò, O., Cusato, J., Lanzafame, M., Trentalange, A., Marinaro, L., Siccardi, M., D'Avolio, A., Galli, M., Di Perri, G.Language:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dkv208
Date:
July, 2015
File:
PDF, 171 KB
english, 2015